BioNTech's BNT324 aims to outpace rivals in cancer treatment with its unique bispecific antibody design. Read more here.

More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.

Nagpur: \"Don't shun diagnostic tests; they are preventive measures against antibiotic resistance,\" declared experts at the ...

The EIB and BPCE banking group have signed an agreement to provide €200 million in loans for SMEs and mid-caps in the French farming and bioecono ...

EV-Grade Durability: Featuring advanced LiFePO4 battery tech, the Exodus 2400 retains 80% capacity after 3,500 cycles-enough ...

Previously disclosed data for troculeucel in Alzheimer's disease and solid tumors can be found on the Company's website at https://nkgenbiotech.com/scientific-publications/. News releases containing ...

Today's Forbes Daily newsletter covers a tariff on films produced abroad, AI startup hustle culture, an exclusive look at ...

“This presentation reflects our focus on developing non-invasive, scalable diagnostics rooted in the promise of liquid biopsy innovation,” said Holly Magliochetti, CEO of PanGIA Biotech. “We remain ...

"This presentation reflects our focus on developing non-invasive, scalable diagnostics rooted in the promise of liquid biopsy innovation," said Holly Magliochetti, CEO of PanGIA Biotech.

today announced that an abstract co-authored by researchers from PanGIA Biotech, Entopsis Inc., and Genetics Institute of America has been accepted for presentation at the 2025 Annual Meeting of the ...